Collaborate Disseminate
The first results from Phase 3 trials testing MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) have been announced. The extremely promising data are the first Phase 3 results to be revealed for any psychedelic-based therapy, paving… Continue reading First Phase 3 trial data for MDMA therapy sets path for approval
Surfing the wave of novel research into medical uses for psychedelic compounds, the Icahn School of Medicine at Mount Sinai has launched a dedicated psychedelic center focusing initially on the study of MDMA and psilocybin for PTSD and other stress-rel… Continue reading Psychedelic research center launched at New York’s Mount Sinai
In the late 1970s and early 1980s MDMA was often utilized to help facilitate positive results in couples counseling. A few dozen pioneering psychotherapists in the United States explored the drug’s therapeutic uses until the US government declared MDMA… Continue reading MDMA-assisted couples therapy investigated in landmark pilot trial
The majority of post-traumatic stress disorder (PTSD) patients suffer from frequent traumatic nightmares that can deeply disrupt sleep patterns and have been linked with significantly higher rates of suicide. The U.S. Food and Drug Administration (FDA)… Continue reading FDA approves prescription-only Apple Watch app for PTSD nightmares
The majority of post-traumatic stress disorder (PTSD) patients suffer from frequent traumatic nightmares that can deeply disrupt sleep patterns and have been linked with significantly higher rates of suicide. The U.S. Food and Drug Administration (FDA)… Continue reading FDA approves prescription-only Apple Watch app for PTSD nightmares
Researchers from University College London have conducted the world’s first meta-analysis of the relationship between post-traumatic stress disorder (PTSD) and dementia. Encompassing over a million subjects the study found PTSD, especially if left untr… Continue reading Metastudy finds PTSD can double the risk of dementia
A newly published pilot study has demonstrated nitrous oxide, commonly known as laughing gas, may help military veterans suffering from post-traumatic stress disorder (PTSD). A larger trial is now underway after several small studies in recent years ha… Continue reading Nitrous oxide being trialed to treat depression, PTSD and alcoholism
A new study published in the journal Psychopharmacology is presenting a comprehensive look at the long-term efficacy of MDMA-assisted psychotherapy for the treatment of post-traumatic stress disorder (PTSD). The study finds not only do the substantial … Continue reading Impressive long-term benefits of MDMA for treating PTSD, study reports
Long-term memories associated with shocking events can be profoundly damaging to sufferers of post-traumatic stress disorder, but could there be a way for science to intervene and lessen the psychological harm? Researchers at Tokyo Metropolitan Univers… Continue reading Traumatic memories erased in fruit flies by keeping them in the dark
In one of the largest, and most detailed studies of its kind conducted to date, a team of researchers examined data from over 150,000 US war veterans and found eight specific genetic regions that seem to confer an increased risk of developing… Continue reading Large veteran study homes in on genetic risk factors for PTSD